Adipose tissue banking is most valuable for adults who are healthy enough to have the harvest procedure, motivated by a proactive approach to their long-term health, and in a life stage where preserving high-quality cells now gives them meaningful option value against the ADSC clinical trial and approval pipeline. It is not a service that is equally valuable for everyone, and an honest assessment of who benefits most helps the right patients make a confident decision while helping others understand whether their specific situation warrants a deeper conversation before proceeding. This post walks through the ideal candidate profile, the factors that strengthen the case for banking, the situations that require physician input first, and the situations where banking may not be the right next step.
TLDR: The ideal banking candidate is a healthy adult aged 30 to 65, proactive about their health, without conditions that make the harvest procedure inadvisable, and motivated by either longevity preservation or a specific personal or family health history relevant to the ADSC pipeline. Banking is most valuable earlier. It is less valuable for patients whose cell quality is already significantly compromised by advanced age or serious systemic disease. Physician consultation first is appropriate for patients with complex health histories.
Important Disclaimer: This post provides a general framework for evaluating whether banking may be appropriate. It is not a medical assessment of any individual’s candidacy. Only a physician who knows your health history can determine whether the harvest procedure is appropriate for you. Banking does not treat, cure, or prevent any disease. All content is for educational purposes only and does not constitute medical advice.
Banking works best as a proactive decision rather than a reactive one. The patients who get the most value from banking are the ones who act before they have a reason to urgently need their cells, because those are exactly the patients whose cells are highest quality, whose harvest is most straightforward, and who have the most time ahead of them to benefit from the pipeline being built. The patients who bank under the most biological pressure, meaning after years of systemic disease or after significant age-related quality decline, are banking under more difficult conditions and with a narrower window for the biological value of preservation to accrue.
That is not a reason to disqualify anyone from exploring banking. It is a reason to understand clearly who gets the most from it, so patients in stronger-fit situations can proceed confidently and patients in weaker-fit situations can evaluate whether and how to proceed with appropriate physician input.
Five factors determine whether banking is a strong fit for a given patient. Work through each one honestly.
The Five Factors That Determine Banking Fit
Factor 1: Age and Biological Timing
Banking is most biologically valuable in the window roughly between ages thirty and sixty-five, with earlier banking within that range generally producing higher-quality cells. Published research documents measurable declines in ADSC proliferative capacity and differentiation potential with age and with systemic disease burden, and the long-term cryopreservation literature establishes that once cells are cryopreserved the biological clock stops but not before.
A strong fit is an adult aged thirty to fifty-five in good general health, whose cells are at a biological quality point where the preservation value is highest and whose life ahead offers the longest window for the pipeline to mature. A good fit is an adult aged fifty-five to sixty-five in good health, whose cells are lower quality than they were at forty but are still worth preserving and are still substantially better than they will be at seventy-five. A weaker fit is an adult over seventy with significant systemic disease burden, where cell quality may be substantially reduced and physician input on harvest suitability is particularly important. Being older than fifty-five is not a disqualifier by itself, because the cells at sixty are better than the cells at seventy. It changes the calculus and makes the physician consultation more important. Save My Fat’s overview of cryopreservation viability covers the preservation side of the argument in more depth.
Factor 2: General Health and Harvest Candidacy
The harvest is a thirty-minute outpatient procedure under local anesthesia. Most adults in reasonable health are candidates. The procedure requires sufficient adipose tissue at the harvest site (abdomen or flank), tolerance of local anesthesia, and no active conditions that would make minor outpatient procedures inadvisable.
A strong fit is a healthy adult with no significant comorbidities, not on anticoagulants, and without active infections or inflammatory flares at the harvest site. Candidates who require physician input before booking include patients on anticoagulant therapy (because anticoagulation management around any minor procedure deserves the prescribing physician’s input), patients with active autoimmune flares (because harvest timing during relative disease stability is generally preferable), patients with prior abdominal surgeries near the harvest site (because anatomical considerations may affect the technique or harvest site), and patients with conditions that affect wound healing. Patients whose current health status makes any outpatient procedure inadvisable are not candidates without physician clearance, and banking should not be pursued in those cases until the underlying health concerns are addressed. The regulatory framework at 21 CFR Part 1271 governs the compliant chain-of-custody for the harvest, and Save My Fat’s resource on questions to ask before banking covers the pre-consultation checklist in more depth.
Factor 3: Motivation Type, Longevity Preservation vs. Condition-Specific
Banking candidates fall into two motivation categories, both valid, with slightly different profiles.
The longevity preservation patient is a healthy adult with no current condition, banking as biological insurance against future need. The best fit profile here is a patient in their thirties to fifties with a health-forward orientation, cash-pay health investment experience, and comfort with option-value reasoning as a decision framework. For this patient, banking is an extension of the same preventive mindset that drives continuous glucose monitoring, annual bloodwork, genetic testing, and other longevity practices.
The condition-specific patient is an adult with an existing condition or strong family history relevant to the ADSC pipeline, such as joint disease, autoimmune diagnosis, or neurological family history. The best fit profile here is a patient whose condition is early or in remission (because active severe disease reduces cell quality and may affect harvest feasibility), whose physician has reviewed and approved the harvest, and who understands that banking is preservation rather than treatment. The 2018 MSC clinical review covers the effects of disease state on MSC quality in more depth, and Save My Fat’s overview of expanded access programs covers the framework for condition-specific patients who may want to combine banking with pursuit of investigational therapy through the expanded access pathway.
Factor 4: Relevant Personal or Family Health History
Certain health histories make the ADSC pipeline particularly relevant and strengthen the specific option value of banking. A joint disease history or family history connects directly to the orthopedic ADSC trials (knee osteoarthritis, cartilage defects, hip disease), which are the most mature application category. An autoimmune diagnosis or family history (Crohn’s disease, multiple sclerosis, lupus, rheumatoid arthritis) connects to active Phase 2 trial activity across all categories. A neurological family history (Parkinson’s disease, ALS, multiple sclerosis) connects to the earlier-stage but active neurological pipeline. An aesthetic or reconstructive history (fat grafting, breast reconstruction, significant scarring) connects to the most commercially mature ADSC application category.
None of these is required for banking, and the absence of any specific relevant history does not disqualify a patient. But any of them strengthens the specific relevance of the pipeline being preserved access to, and patients with one or more relevant histories tend to have clearer answers to the question “what am I preserving this for” than patients banking purely for general longevity reasons. The active ADSC trial pipeline on ClinicalTrials.gov lets any patient review the trial activity in their specific indication area of interest, and Save My Fat’s patient-facing introduction to adipose-derived stem cells covers the underlying biology that supports the cross-indication relevance.
Factor 5: Financial Fit
Banking costs between $8,000 and $15,000 for the initial package plus annual storage. It is cash-pay. It should be a considered but not financially stressful decision.
A strong fit is a patient for whom the cost is within the discretionary health investment budget without creating financial strain, and for whom the annual storage fees are a manageable ongoing expense. A situation that requires more thought is one where the cost requires financing or creates meaningful financial pressure, because banking under financial strain changes the emotional calculus around the decision and can create regret later. Banking is not appropriate when the cost would require taking on debt or compromising essential financial obligations, and a patient in that position should defer banking until their discretionary health budget can absorb the cost comfortably. Current pricing is published on the Save My Fat website at savemyfat.com/pricing, and Save My Fat’s complete guide to banking covers the financial decision framework in more depth.
The Strong-Fit Profile at a Glance
A patient who scores strongly on all five factors tends to look similar across most cases. Age thirty-five to fifty-five, in good general health. No conditions that make a thirty-minute outpatient procedure inadvisable. Health-forward orientation, already investing in preventive or longevity health practices. Personal or family history relevant to the orthopedic, autoimmune, neurological, or aesthetic ADSC pipeline, even if the relevance is modest rather than acute. Banking cost within the discretionary health budget without financial strain.
This patient gets the highest biological value from banking, because the cell quality is highest, the harvest is most straightforward, and the years ahead for the pipeline to develop are longest. The decision for this patient is typically not whether to bank but when, and the answer is usually now rather than later because each year of delay reduces the cell quality that can be preserved.
The Good-Fit-With-Conditions Profile
Some patients are good candidates but need additional steps before booking. An adult aged fifty-five to sixty-five in good general health is a good candidate but benefits from a physician consultation specifically confirming harvest suitability before proceeding. A patient with an active autoimmune condition in remission is a good candidate, but harvest timing during relative disease stability matters, so physician consultation should precede booking to coordinate timing around the disease course. A patient on anticoagulant therapy is a good candidate but should discuss harvest timing and peri-procedure anticoagulation management with the prescribing physician before booking, because anticoagulation adjustments around minor procedures deserve careful clinical coordination.
A patient with no specific health history relevance but a strong longevity motivation is a valid candidate, though the specific option value is lower than for a patient with directly relevant history. This patient should understand that the pipeline they are preserving access to is general rather than condition-specific, and should be comfortable with the more abstract value proposition that flows from that framing. The published MSC biology literature covers the cross-cutting biological mechanisms that support general rather than condition-specific preservation value, and Save My Fat’s resource on questions to ask before banking is the appropriate starting point for any patient with open questions before consultation.
Situations Where Banking Is a Weaker Fit
Honesty matters more here than in any other part of this post. Banking is less compelling in these situations, and patients in them deserve an honest framework rather than a marketing pitch.
Advanced age combined with significant systemic disease burden reduces the biological value of preservation. Cell quality may be substantially reduced in this context, and the return on investment is correspondingly reduced. Banking is still possible in many cases, but the calculus is different and physician input is particularly important before proceeding. Active severe autoimmune flare or active serious illness affects both cell quality at the time of harvest and the advisability of the harvest procedure itself, and banking during active disease states is generally better deferred to a period of relative stability. Financial strain is a legitimate reason to wait. If the cost creates meaningful financial pressure, the option value does not justify financial stress, and banking should be a comfortable decision rather than a reluctant one. Expectation of immediate benefit is a misunderstanding of what banking is. Banking is preservation for potential future use, not a treatment. Patients who expect a near-term therapeutic benefit from banking itself have misunderstood the service, and Save My Fat’s comparison of banking vs. stem cell treatment clinics covers the critical distinction between preservation and treatment in more depth.
The Self-Assessment Checklist
Before booking a consultation, work through this checklist honestly. Check each box only if you can answer yes confidently.
Health:
- [ ] I am in good general health and am a reasonable candidate for a thirty-minute outpatient procedure under local anesthesia.
- [ ] I do not have active conditions that make minor outpatient procedures inadvisable.
- [ ] If I am on anticoagulants or have relevant surgical history near the harvest site, I have or will discuss this with my physician before booking.
Motivation:
- [ ] I understand that banking is tissue preservation, not a treatment.
- [ ] I am banking for long-term option value, not expecting immediate therapeutic benefit.
- [ ] I have a specific or general reason why the ADSC pipeline is relevant to my health future.
Financial:
- [ ] The cost of banking is within my discretionary health investment budget without financial strain.
- [ ] I have reviewed the pricing information and understand what is included in the package.
- [ ] I understand that annual storage fees apply after year one.
If you checked all boxes, you are ready to book a consultation, and Save My Fat’s provider page is the right next step. If you have open items, Save My Fat’s resource on questions to ask before banking is the right starting point, because the question guide walks through the open areas systematically.
Frequently Asked Questions
I am sixty-two. Is it too late to bank?
No, but earlier is better for cell quality. A sixty-two-year-old in good health can bank effectively. The cells preserved at sixty-two are lower quality than at forty-five based on the published cryopreservation and MSC longevity literature, but they are still your cells at their current best, and they are better than the cells you will have at seventy-two. Physician consultation before the harvest is recommended at this age to confirm suitability, and the physician consultation is also useful for identifying any factors that might affect harvest timing or approach.
I have rheumatoid arthritis. Can I still bank?
Banking with an autoimmune condition is possible and often particularly motivated, because the autoimmune ADSC trial pipeline is active and specifically relevant to patients in this category. The key is timing the harvest during a period of relative disease stability rather than during an active flare, because cell quality and harvest feasibility both benefit from stable rather than active disease states, as the 2018 MSC clinical review documents. Discuss timing with your rheumatologist and a Save My Fat provider to coordinate the harvest around your disease course.
I am very lean and do not have much belly fat. Can I still bank?
Sufficient adipose tissue at the harvest site is required for the procedure. A Save My Fat provider will assess tissue availability at the consultation. Most adults have sufficient tissue at the abdomen or flank for a banking harvest even if they are lean, because the volume required is modest rather than substantial. Discuss your body composition specifically with the provider at consultation, and the provider can advise on whether the available tissue is adequate for the harvest.
I do not have any specific health concerns. Is banking still worth it?
Yes, for the right patient. The longevity preservation patient, a healthy adult with no current condition banking as biological insurance, is one of the two primary candidate profiles for banking. The value is option value against future need rather than current clinical relevance, and the foundational Zuk 2002 paper established the scientific basis for why autologous adipose cells are worth preserving even in the absence of a specific current indication. Patients in this profile should be comfortable with the option-value reasoning that makes the case, and should not expect immediate therapeutic benefit from banking itself.
Key Takeaways
The ideal banking candidate is a healthy adult aged thirty to sixty-five with a proactive health orientation, no contraindications to a minor outpatient procedure, and the financial flexibility to make banking a comfortable decision rather than a financially stressed one. This profile captures most of the patient population that gets the strongest biological and practical value from banking.
Banking is most biologically valuable earlier, because cell quality declines with age and disease and cannot be recovered once lost. The cells you bank today are the best version you will have to preserve. Each year of delay reduces the preservation value, which is the single most important timing fact in the banking decision.
Two valid motivation profiles exist side by side. Longevity preservation, where a healthy adult banks as biological insurance against future need, is the right frame for patients engaged in broader longevity and preventive health practices. Condition-specific, where a patient with a personal or family history relevant to the ADSC pipeline banks with a more specific future use case in mind, is the right frame for patients whose health history connects them directly to the orthopedic, autoimmune, neurological, or aesthetic research pipelines.
Banking is a weaker fit for advanced age with significant systemic disease burden, for active severe illness or active autoimmune flares, for patients under meaningful financial strain, and for patients expecting immediate therapeutic benefit rather than preservation value. Each of these situations deserves an honest assessment rather than a sales pitch, and patients in any of them may still have a legitimate path to banking with appropriate physician input or with deferred timing.
The self-assessment checklist gives you a clear pre-consultation framework. Check all boxes and book a consultation. Have open items and use the question guide first. The goal of the checklist is not to disqualify anyone but to help each patient identify whether they are ready to move forward now, ready to move forward after addressing a specific open item, or better served by deferring the decision for now.
Next Steps
Before moving forward: adipose tissue banking is a preservation service for potential future use in FDA-regulated pathways, not a treatment or a guarantee of access to any specific clinical trial, therapy, or product. No adipose-derived product is FDA-approved for general disease treatment, and banking cannot be represented as a treatment for any condition. Consult your physician about whether banking is appropriate for your specific situation. Physicians considering partnership should independently verify applicable state licensing and informed-consent requirements, particularly in Florida, Utah, and Nevada, which have stem cell-specific statutes.
To prepare your questions for a consultation, visit the resource on questions to ask before banking. To find a partner provider near you, visit the provider page. To review current pricing, visit savemyfat.com/pricing.
Save My Fat provides adipose tissue banking services in partnership with L2 Bio for laboratory operations. Save My Fat does not provide medical treatments, clinical trial enrollment, or Expanded Access services.
This article is for educational purposes only and does not constitute medical or legal advice. Legal and medical review including neurology and neurosurgery input is required before publication. Please consult your neurologist or neurosurgeon before making any decisions about neurologic treatment or research participation.
